Ovid Therapeutics
OVID
OVID
103 hedge funds and large institutions have $233M invested in Ovid Therapeutics in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 33 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
23% more funds holding
Funds holding: 84 → 103 (+19)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less call options, than puts
Call options by funds: $341K | Put options by funds: $411K
Holders
103
Holding in Top 10
1
Calls
$341K
Puts
$411K
Top Buyers
| 1 | +$19.2M | |
| 2 | +$10.1M | |
| 3 | +$9.31M | |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$6.23M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.78M |
Top Sellers
| 1 | -$3.99M | |
| 2 | -$2.01M | |
| 3 | -$1.47M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$769K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$698K |
